Clinical Activity and Tolerability of a 14-Day Infusional Ifosfamide Schedule in Soft-Tissue Sarcoma

Figure 1

Median PFS: 4.2 months (95% CI: 2.0–6.3). PFS rate at 1 year: 19.2%. Median followup: 6.7 months.